Search results
Expect 'theater' in House Appropriations hearing, says Maryland Rep Steny Hoyer
WUSA 9 Washington, D.C.· 17 hours agoFormer House Majority Leader and Maryland Democrat Steny Hoyer tells WUSA9 he’s prepared for...
Madison budget gap now at $22M: New estimates bring fiscal dillema into sharper focus
Wisconsin State Journal· 3 days agoMadison’s budget gap will be $22 million in 2025 as officials have revised it down from their...
Agency cybersecurity incidents grew by almost 10% last year
Federal News Network· 4 days agoThe number of cybersecurity incidents in 2023 grew by almost 10%. Agencies reported more than 32,000 cyber incidents to the Cybersecurity and Infrastructure Security Agency in fiscal 2023. The ...
CarParts.com, Inc. (NASDAQ:PRTS) Director Jim Barnes Purchases 94,000 Shares of Stock
ETF DAILY NEWS· 2 days agoCarParts.com, Inc. (NASDAQ:PRTS – Get Free Report) Director Jim Barnes bought 94,000 shares of CarParts.com stock in a transaction dated Tuesday, June 11th. The shares were acquired at an average ...
JD Supra: Federal Agencies Take Sweeping Action on AI in Accordance with AI EO — AI: The Washington...
JD Supra· 5 days agoPresident Joe Biden’s October 2023 Executive Order on AI directed agencies to institute a significant number of actions on AI. On April 29, 2024, the White House announced that federal agencies ...
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Insider Thomas Gad Sells 35,000 Shares
ETF DAILY NEWS· 2 days agoY-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) insider Thomas Gad sold 35,000 shares of the stock in a transaction dated Monday, June 10th. The stock was sold at an average price ...
MidAtlantic People: June 2024
Engineering News-Record· 4 days agoNigel Astell has joined design firm WSP as intercity rail and strategy leader in Washington, D.C. He now oversees major project delivery and strategic...
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives $9.33 Consensus Target Price from Analysts
ETF DAILY NEWS· 2 days agoEsperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) has earned an average rating of “Hold” from the five analysts that are currently covering the company, MarketBeat reports. Three research ...
Hamas responds to Gaza cease-fire plan seeking some changes. US says it's 'evaluating' the reply
St. Louis Post-Dispatch· 2 days agoHamas said Tuesday that it gave mediators its reply to the U.S.-backed proposal for a cease-fire in...
Esperion Therapeutics Target of Unusually High Options Trading (NASDAQ:ESPR)
ETF DAILY NEWS· 2 days agoEsperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw some unusual options trading activity on Monday. Investors bought 5,316 call options on the stock. This represents an increase ...